Joanne M. Foody - 14 Mar 2022 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role: Chief Medical Officer
Signature: /s/ Richard B. Bartram, by power of attorney
Issuer symbol: ESPR
Transactions as of: 14 Mar 2022
Net transactions value: $0
Form type: 4
Filing time: 16 Mar 2022, 17:10:12 UTC
Previous filing: 01 Nov 2021
Next filing: 09 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ESPR	Common Stock	Award	$0	+28,000	+33%	$0.000000	112,978	14 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ESPR	Stock Option (right to buy						119,000	14 Mar 2022	Common Stock	119,000	$4.74	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Such award will vest over a four (4) year period as follows: 25% shall vest on the one year anniversary of March 15, 2022 and the remainder shall vest in equal quarterly installments over the three (3) year period thereafter, subject to continued service.